IDEAS home Printed from https://ideas.repec.org/p/ohe/grafun/002521.html

The commercial case for investing in ALS

Author

Listed:
  • Brittany Darrow
  • Priscila Radu
  • Amanda Cole

Abstract

Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive neurodegenerative disease with devastating clinical and economic consequences.

Suggested Citation

  • Brittany Darrow & Priscila Radu & Amanda Cole, 2025. "The commercial case for investing in ALS," Grant-Funded Research 002521, Office of Health Economics.
    • Handle: RePEc:ohe:grafun:002521
    as

    Download full text from publisher

    File URL: https://www.ohe.org/publications/the-commercial-case-for-investing-in-als/
    Download Restriction: no
    File URL: https://www.ohe.org/wp-content/uploads/2025/11/Darrow-B.-at-al.-2025-The-commercial-case-for-investing-in-ALS.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Xia, Qing & McPhail, Steven M & Afoakwah, Clifford & Vo, Linh K & Lim, Megumi & Brain, David & Kuwornu, John Paul & Carter, Hannah E., 2025. "Growth and changing landscape of the cost-utility literature: an Australian perspective, 1992-2022," Health Policy, Elsevier, vol. 156(C).
    2. J. Pöhlmann & K. Norrbacka & K. S. Boye & W. J. Valentine & H. Sapin, 2020. "Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(8), pages 1179-1196, November.
    3. Michela Meregaglia & Francesco Malandrini & Aureliano Paolo Finch & Oriana Ciani & Claudio Jommi, 2023. "EQ-5D-5L Population Norms for Italy," Applied Health Economics and Health Policy, Springer, vol. 21(2), pages 289-303, March.
    4. Pierluigi Russo & Matteo Zanuzzi & Angelica Carletto & Annalisa Sammarco & Federica Romano & Andrea Manca, 2023. "Role of Economic Evaluations on Pricing of Medicines Reimbursed by the Italian National Health Service," PharmacoEconomics, Springer, vol. 41(1), pages 107-117, January.
    5. Afschin Gandjour, 2023. "A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany," Applied Health Economics and Health Policy, Springer, vol. 21(4), pages 627-635, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lidia García-Pérez & Ignacio Abásolo-Alessón & Miguel Ángel Negrín-Hernández, 2026. "Exploring the Generalizability of Foreign Cost-Effectiveness Analysis to Spain Using Data From a Scoping Review of Multinational Studies," PharmacoEconomics, Springer, vol. 44(1), pages 43-60, January.
    2. Caimmi, Michele & Canali, Beatrice & Candelora, Laura & Di Costanzo, Alessandra & Fiorentino, Francesca & Vassallo, Chiara & Mancusi, Maria Luisa, 2025. "Price regulation and competition among on-patent anticancer drugs in Italy," Health Policy, Elsevier, vol. 157(C).
    3. Maura Leusder & Hilco J. Elten & Kees Ahaus & Carina G. J. M. Hilders & Evert J. P. Santbrink, 2025. "Patient-level cost analysis of subfertility pathways in the Dutch healthcare system," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 26(6), pages 927-943, August.
    4. Susanne Mayer & Agata Łaszewska & Judit Simon, 2022. "Unit Costs in Health Economic Evaluations: Quo Vadis, Austria?," IJERPH, MDPI, vol. 20(1), pages 1-12, December.

    More about this item

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:grafun:002521. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Publications Manager The email address of this maintainer does not seem to be valid anymore. Please ask Publications Manager to update the entry or send us the correct address (email available below). General contact details of provider: https://edirc.repec.org/data/ohecouk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.